Ireland - English - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - amoxicillin trihydrate; clavulanic acid - film-coated tablet - 875/125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - powder for suspension - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - powder for suspension - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 286.9 mg (equivalent: amoxicillin trihydrate, qty 250 mg); potassium clavulanate, quantity: 149.5 mg (equivalent: clavulanic acid, qty 125 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate; magnesium stearate; microcrystalline cellulose; dimeticone 200; titanium dioxide; propylene glycol; hypromellose; ethylcellulose - augmentin is indicated in the treatment of the following infections when caused by augmentin sensitive, beta-lactamase producing organisms: skin and skin structure infections, including cases caused by beta-lactamase producing s. aureus, e. coli and klebsiella spp. (only some strains may be sensitive). urinary tract infections, including cases caused by beta-lactamase producing e. coli, p. mirabilis & klebsiella spp. upper respiratory tract infections, such as sinusitis, including cases caused by beta-lactamase producing h.influenzae and m.catarrhalis, and otitis media, especially cases caused by beta-lactamase producing h. influenzae, m. catarrhalis and s. aureus. lower respiratory tract infections, especially cases caused by beta-lactamase producing h.influenzae and m.catarrhalis. appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to augmentin. however, when there is reason to believe an infection may involve any

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - amoxicillin trihydrate clavulanic acid - powder for oral suspension - 400/57 mg/5ml

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - clavulanate potassium; amoxicillin trihydrate - powder for oral suspension - 400/57 mg/5ml - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - amoxicillin trihydrate, clavulanate potassium - powder for oral suspension - 400/57 mg/5ml - combinations of penicillins, incl. beta-lactamase inhibitors

Malta - English - Medicines Authority

smithkline beecham plc - amoxicillin 400 mg/5ml, clavulanic acid 57 mg/5ml - powder for oral suspension

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - amoxicillin trihydrate, clavulanic acid (in the form of potassium clavulanate) - powder for oral suspension - 400/57 mg/5ml - combinations of penicillins, incl. beta-lactamase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline consumer healthcare (ireland) limited - amoxicillin trihydrate clavulanate potassium - film coated tablet - 875/125 milligram